Tandem Diabetes Care, Inc.
MX ˙ BMV ˙ US8753722037
SecurityMX:TNDM / Tandem Diabetes Care, Inc.
InstitutionCI Private Wealth, LLC
Latest Disclosed Ownership33,741 shares
Latest Disclosed Value $ 636,658
CI Private Wealth, LLC reports 72.72% increase in ownership of TNDM / Tandem Diabetes Care, Inc.

On May 15, 2026 - CI Private Wealth, LLC filed a 13F-HR form disclosing ownership of 33,741 shares of Tandem Diabetes Care, Inc. (MX:TNDM) valued at $636,658 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 9, 2026 disclosing 19,535 shares of Tandem Diabetes Care, Inc.. This represents a change in shares of 72.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 33,741 14,206 72.72 637 48.25 0.0009
2026-03-09 2025-12-31 13F/A-1 TANDEM DIABETES CARE COM NEW 875372203 19,535 19,535 429 0.0006
2026-02-19 2025-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 15,748 15,748 306 0.0001
2025-11-14 2025-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 0 -11,800 -100.00 0 -100.00
2025-09-26 2025-06-30 13F/A-1 TANDEM DIABETES CARE COM NEW 875372203 11,800 531 4.71 220 1.86 0.0003
2025-08-15 2025-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 23,600 12,331 440 0.0004
2025-05-14 2025-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 11,269 3,425 43.66 216 -23.76 0.0004
2025-02-10 2024-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 7,844 962 13.98 283 -3.09 0.0005
2024-11-12 2024-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 6,882 -3,428 -33.25 292 -29.88 0.0005
2024-08-13 2024-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 10,310 4 0.04 415 14.01 0.0007
2024-05-09 2024-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 10,306 286 2.85 365 22.97 0.0006
2024-02-09 2023-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 10,020 10,020 296 0.0005
2023-08-10 2023-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 0 -6,272 -100.00 0 -100.00
2023-05-15 2023-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 6,272 6,272 255 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.